Trial Profile
Pharmacokinetic study comparing plasma and intracellular Imatinib concentrations in patients with chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacokinetics
- 27 Nov 2015 New trial record